BA

Bindu Acharya

Active Director Director DIN 07223003
DIN 07223003 First appointment Jul 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Jul 2015
Shareholding value •••• Premium profile

About Bindu Acharya

Data last updated:

Bindu Acharya is a Director at Rajasthan Antibiotics Ltd (since 2022) and Director at Tarc Limited (since 2023). The companies operate in Pharma, Real Estate and Construction and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹422 Cr; the largest is Rajasthan Antibiotics Ltd at ₹383 Cr (FY 2025). Earlier, Bindu Acharya was a Nominee Director at Millennium City Expressways Private Limited (2015–2019).

DIN 07223003
Primary Designation Director
Industry Pharma
First Appointment 15 Jul 2015
Oldest Company Age 40 yrs
Largest company Rajasthan Antibiotics Ltd · ₹383 Cr (FY 2025)
Combined revenue ₹422 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rajasthan Antibiotics Ltd U24231DL1986PLC023616
Director03 Jan 20221986₹383 Cr (FY 2025)Active
Tarc Limited L70100DL2016PLC390526
Director13 Feb 20232016₹38.89 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director15 Jul 20152014₹4,000 (FY 2024)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Bindu Acharya

NameDINCompanyDesignation
Aashish Pruthii01182469Rajasthan Antibiotics LtdManaging Director
Arvind Kharabanda00052270Rajasthan Antibiotics LtdDirector
Rajesh Kumar Jha08345857Rajasthan Antibiotics LtdDirector
Rakesh Kumar Girdhar02380490Rajasthan Antibiotics LtdWhole-Time Director
Sanjay MittalRajasthan Antibiotics LtdCfo
Vijaysinh Vanvirsinh Chauhan07105066Rajasthan Antibiotics LtdDirector
Amar Sarin00015937Tarc LimitedManaging Director
Amar SarinTarc LimitedCeo
Ambarish Chatterjee00653680Tarc LimitedDirector
Amit NarayanTarc LimitedCompany Secretary
Anil Sarin00016152Tarc LimitedDirector
Jyoti Ghosh08217481Tarc LimitedDirector
Miyar Ramanath Nayak03352749Tarc LimitedDirector
Muskaan Sarin01871183Tarc LimitedDirector
Nitin Kumar GoelTarc LimitedCfo

Directorship timeline

Open interactive timeline →
Tarc Limited
Rajasthan Antibiotics Ltd
Millennium City Expressways Private Limited
Premium access

Shareholding and investment profile for Bindu Acharya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bindu Acharya

Bindu Acharya currently holds 2 directorships: Rajasthan Antibiotics Ltd (Director, since 03 Jan 2022, revenue ₹383 Cr (FY 2025)); Tarc Limited (Director, since 13 Feb 2023, revenue ₹38.89 Cr (FY 2025)).

Bindu Acharya was first appointed on 15 Jul 2015 as Nominee Director at Millennium City Expressways Private Limited. The most recent appointment on record is 13 Feb 2023 at Tarc Limited.

The 2 current companies of Bindu Acharya that report revenue have a combined latest revenue of ₹422 Cr: Rajasthan Antibiotics Ltd ₹383 Cr (FY 2025); Tarc Limited ₹38.89 Cr (FY 2025).

Bindu Acharya held 1 earlier board appointment: Millennium City Expressways Private Limited (Nominee Director, 15 Jul 2015 to 15 Jul 2019).

The current boards of Bindu Acharya's companies include Aashish Pruthii (Rajasthan Antibiotics Ltd), Arvind Kharabanda (Rajasthan Antibiotics Ltd), Rajesh Kumar Jha (Rajasthan Antibiotics Ltd), Rakesh Kumar Girdhar (Rajasthan Antibiotics Ltd), Sanjay Mittal (Rajasthan Antibiotics Ltd), Vijaysinh Vanvirsinh Chauhan (Rajasthan Antibiotics Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available